PEARL BIO, INC.
STTR Phase I award from Department of Defense.
Summary
Pearl Bio, Inc. received STTR Phase I funding to develop a scalable method for producing sequence-defined biopolymers that incorporate aramid materials. The project uses genomically recoded biological systems to enable efficient manufacturing of these advanced polymers.
- Amount
- $249,967
- Agency
- Department of Defense · Department of the Army
- Program / Phase
- STTR · Phase I
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- MA
- Period
- 2026-04-01 → 2027-03-31
Technology domains
Materials & Manufacturing
Description
SMALL BUSINESS TECHNOLOGY TRANSFER RESEARCH (STTR) SERVICES PHASE I EFFORT TITLED SCALABLE PRODUCTION OF SEQUENCE-DEFINED BIOPOLYMERS CONTAINING ARAMIDS IN GENOMICALLY RECODED SYSTEMS.